Ansa Biotechnologies, founded in 2018 and headquartered in Emeryville, California, is a biotechnology company specializing in enzymatic DNA synthesis. Their proprietary technology enables the synthesis of complex DNA sequences, including those with high GC or AT content, strong secondary structures, and repetitive elements, which are often challenging using traditional synthesis methods. Ansa's services cater to various industries, including healthcare, pharmaceuticals, biological research, food and agriculture, and industrial biotechnology.